Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Invested Capital (2016 - 2025)

Historic Invested Capital for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.

  • Bio-Techne's Invested Capital fell 324.77% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 324.77%. This contributed to the annual value of $1.9 billion for FY2025, which is 725.24% down from last year.
  • Latest data reveals that Bio-Techne reported Invested Capital of $2.0 billion as of Q4 2025, which was down 324.77% from $2.0 billion recorded in Q3 2025.
  • Bio-Techne's 5-year Invested Capital high stood at $2.1 billion for Q3 2024, and its period low was $1.8 billion during Q3 2022.
  • Over the past 5 years, Bio-Techne's median Invested Capital value was $2.0 billion (recorded in 2023), while the average stood at $2.0 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 968.6% in 2022, then skyrocketed by 1370.11% in 2023.
  • Quarter analysis of 5 years shows Bio-Techne's Invested Capital stood at $2.0 billion in 2021, then decreased by 7.97% to $1.8 billion in 2022, then rose by 7.47% to $2.0 billion in 2023, then rose by 5.85% to $2.1 billion in 2024, then decreased by 3.25% to $2.0 billion in 2025.
  • Its Invested Capital was $2.0 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $1.9 billion in Q2 2025.